Peptide Therapy in California

Global GMP peptide CDMO with North American headquarters in Torrance, CA. One of the world's largest dedicated peptide manufacturers. Specializes in peptide API manufacturing from Phase I through commercial scale.

Bachem is a global leader in peptide and oligonucleotide manufacturing with US operations in Torrance, CA. Offers full GMP manufacturing services for peptide APIs and finished dosage forms. Serves biopharma companies developing peptide-based therapeutics worldwide.

US subsidiary of Swiss-based Bachem Holding, a global leader in peptide chemistry. FDA-registered and GMP-compliant. Provides full-service CDMO capabilities from process development to large-scale commercial API production.

California-based peptide synthesis and manufacturing company offering custom peptide synthesis, GLP and GMP manufacturing, and research-grade peptides. Serves academic institutions, biotech companies, and pharmaceutical developers with high-quality custom peptide APIs.

Leading biotech CMO with 30+ years of peptide manufacturing experience. 44,000 sq ft facility in California's Silicon Valley. Manufactures custom GMP peptides and dyes for diagnostics, biopharmaceuticals, and cosmetics.

San Diego-based 503B outsourcing facility offering compounded ophthalmology, urology, and specialty medications including peptide-based preparations. FDA-registered, PCAB-accredited, and ships nationally to healthcare providers.

CDMO specializing in large-scale, late-phase, and commercial GMP peptide and oligonucleotide manufacturing. Annual peptide API production capacity exceeds 1,000 kg. Serves clinical and commercial pharmaceutical clients.

Torrance-based 503B pharmaceutical outsourcing facility manufacturing sterile injectable peptide preparations including sermorelin, ipamorelin, and CJC-1295. FDA-registered and ships to licensed practitioners nationally.

Integrated biologics and peptide CDMO with San Diego bioconjugation facilities. Offers end-to-end pharmaceutical development and manufacturing services including custom peptide-drug conjugate production for biopharma.